SHELBY SALTSMAN: Open Payments
NPI 1114566247 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 56 payments from 19 companies in 2025. Trend: 2023 $2,323 · 2024 $3,343 · 2025 $1,630
Food & beverage: $1,530Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $280 |
| E.R. Squibb & Sons, L.L.C. | 10 | $229 |
| Janssen Biotech, Inc. | 4 | $179 |
| Botanix SB Inc | 3 | $175 |
| Regeneron Healthcare Solutions, Inc. | 3 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Lilly USA, LLC | 2 | $66 |
| Organogenesis Inc. | 1 | $65 |
| LEO Pharma Inc. | 2 | $52 |
Products named: Bimzelx, Sotyktu, TREMFYA, SOFDRA, DUPIXENT, LIBTAYO, TALTZ, CYGNUS DUAL.
Industry payments across CA — which companies pay providers there.
